New analyses of two AZD7442 COVID-19 phase-III trials in high-risk populations confirm robust… EP News Bureau Nov 19, 2021 Six months' follow-up of prevention trial showed 83 per cent reduced risk of symptomatic COVID-19, with no severe disease or…
Preparing for the third wave Viveka Roychowdhury Jun 1, 2021 Even if we need global help to meet today's needs, we have to shore up infrastructure for future disruptions
US, India lead in COVID-19 clinical trials benefitted by large patient pools: GlobalData EP News Bureau Apr 8, 2021 The US saw 823 COVID-19 trials in March, followed by India at 491
